Literature DB >> 31943138

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants.

Deepa R J Arachchillage1,2, Keith Gomez3, Raza Alikhan4, Julia A M Anderson5, Will Lester6, Mike Laffan1,2.   

Abstract

Entities:  

Keywords:  Antiphospholipid syndrome; direct acting oral anticoagulants; lupus anticoagulant; arterial thrombosis; venous thrombosis

Year:  2020        PMID： 31943138     DOI： 10.1111/bjh.16308

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

Review 1.  Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?

Authors:  Fionnuala Ní Áinle; Barry Kevane
Journal:  Blood Adv       Date:  2020-11-10

2.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic.

Authors:  Rita Selby; Jameel Abdulrehman
Journal:  J Appl Lab Med       Date:  2022-01-05

Review 3.  Thrombophilia testing in the era of direct oral anticoagulants.

Authors:  Jennifer Darlow; Holly Mould
Journal:  Clin Med (Lond)       Date:  2021-09-07       Impact factor: 5.410

Review 4.  Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

Authors:  Julie Carré; Georges Jourdi; Nicolas Gendron; Dominique Helley; Pascale Gaussem; Luc Darnige
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

5.  Recurrent Mural Thrombosis of the Ascending Aorta in a Patient with Antiphospholipid Syndrome.

Authors:  Ryohei Otsuka; Shunei Saito; Toshikuni Yamamoto; Tsukasa Ohno; Akio Koyama; Hirofumi Morimae; Masahiro Matsushita; Kaori Yokota; Ken Miyahara; Akio Matsuura
Journal:  Ann Vasc Dis       Date:  2022-03-25

Review 6.  Clinical Management of Thrombotic Antiphospholipid Syndrome.

Authors:  Nor Rafeah Tumian; Beverley J Hunt
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

Review 7.  Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants.

Authors:  Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Res Pract Thromb Haemost       Date:  2022-03-15

8.  Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial.

Authors:  Scott C Woller; Scott M Stevens; David Kaplan; Tzu-Fei Wang; D Ware Branch; Danielle Groat; Emily L Wilson; Brent Armbruster; Valerie T Aston; James F Lloyd; Matthew T Rondina; C Greg Elliott
Journal:  Blood Adv       Date:  2022-03-22

9.  Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry.

Authors:  Annabel Schulz; Eva Herrmann; Olivia Ott; Edelgard Lindhoff-Last
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

10.  Direct oral anticoagulants-Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors.

Authors:  Danielle White; Gary W Moore; Martin Besser; Stephen MacDonald; Will Thomas
Journal:  Res Pract Thromb Haemost       Date:  2022-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.